(5R)-5,9-dimethyldecane-1,9-diol | 164025-79-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (5R)-5,9-dimethyldecane-1,9-diol
• 英文别名: (R)-5,9-dimethyl-decane-1,9-diol
• CAS: 164025-79-0
• 化学式: C₁₂H₂₆O₂
• 分子量: 202.337
• InChiKey: RMUBMAIBBDULGC-LLVKDONJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  14
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (5R)-5,9-dimethyldecane-1,9-diol 在 sodium acetate 、 pyridinium chlorochromate 作用下， 以 二氯甲烷 为溶剂， 反应 1.0h， 以44 mg的产率得到(5S)-9-hydroxy-5,9-dimethyldecanal
  参考文献：
  名称：

  Synthesis of Retiferol RAD1 and RAD2, the Lead Representatives of a New Class of des-CD Analogs of Cholecalciferol

  摘要：

  The design and total convergent synthesis are described for the leading representatives of the new class of analogs of cholecalciferol with the CD-ring system replaced with a two-carbon aliphatic spacer. The leading representatives of C-21 retiferols (RAD(1) and RAD(2)) were obtained from a ring fragment derived from vitamin D and a chain fragment obtained from S-(-)-beta-citronellol. (C) 1995 Academic Press, Inc.

  DOI：

  10.1006/bioo.1995.1002
• 作为产物：
  描述：

  (S)-9-Hydroxy-5,9-dimethyl-decanoic acid ethyl ester 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 0.33h， 以67 mg的产率得到(5R)-5,9-dimethyldecane-1,9-diol
  参考文献：
  名称：

  Synthesis of Retiferol RAD1 and RAD2, the Lead Representatives of a New Class of des-CD Analogs of Cholecalciferol

  摘要：

  The design and total convergent synthesis are described for the leading representatives of the new class of analogs of cholecalciferol with the CD-ring system replaced with a two-carbon aliphatic spacer. The leading representatives of C-21 retiferols (RAD(1) and RAD(2)) were obtained from a ring fragment derived from vitamin D and a chain fragment obtained from S-(-)-beta-citronellol. (C) 1995 Academic Press, Inc.

  DOI：

  10.1006/bioo.1995.1002

文献信息

• Des-C,D analogs of 1alpha,25-dihydroxy-19-norvitamin D3
  申请人：DeLuca F. Hector

  公开号：US20070112077A1

  公开（公告）日：2007-05-17

  Des-C,D 2-methylene-19-norvitamin D 3 analogs are provided including compounds of formula 1, in which R 1 is a straight or branched chain alkyl or alkylene group having from 8 to 27 carbons and bearing an Oy 3 group; and y 1 , y 2 and y 3 are independently selected from H or hydroxy-protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological conditions.

  提供了Des-C、D 2-亚甲基-19-去氢维生素D3类似物，包括式1中的化合物，其中R1是具有8至27个碳的直链或支链烷基或烷基烯基基团，并带有一个Oy3基团；而y1、y2和y3是独立选择的H或羟基保护基团。这些化合物可用于制备药物组合物，并可用于治疗各种生物学情况。
• Cyclohexanediol derivatives
  申请人：Hoffmann-La Roche Inc.

  公开号：US05969190A1

  公开（公告）日：1999-10-19

  The compound, (E)-(1R,3R)-5-[(R)-11-hydroxy-7,11-dimethyl-dodec-2-enylidene]-cyclohexane -1,3-diol of the formula I: ##STR1## is useful in the treatment or prevention of hyperproliferative skin diseases, particularly psoriasis, basal cell carcinomas, disorders of keratinization and keratosis; or for reversing the conditions associated with photodamage.

  化合物(E)-(1R,3R)-5-[(R)-11-羟基-7,11-二甲基-十二烯基亚甲基]-环己烷-1,3-二醇，式子为I：##STR1##可用于治疗或预防过度增生性皮肤疾病，特别是银屑病、基底细胞癌、角化症和角化过程紊乱；或逆转与光损伤相关的病症。
• Des-C,D analogs of 1α,25-dihydroxy-19-norvitamin D3
  申请人：Wisconsin Alumni Research Foundation

  公开号：US07534777B2

  公开（公告）日：2009-05-19

  Des-C,D 2-methylene-19-norvitamin D3 analogs are provided including compounds of formula 1, in which R1 is a straight or branched chain alkyl or alkylene group having from 8 to 27 carbons and bearing an OY3 group; and Y1, Y2 and Y3 are independently selected from H or hydroxy-protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological conditions.

  提供了Des-C，D 2-亚甲基-19-去维生素D3类似物，其中包括式子1的化合物，其中R1是直链或支链烷基或烷基链，具有8到27个碳，并带有一个OY3基团；Y1，Y2和Y3是独立选择的H或羟基保护基团。这些化合物可用于制备药物组合物，并且在治疗各种生物状况方面有用。
• WO2007/28000
  申请人：——

  公开号：——

  公开（公告）日：——
• CYCLOHEXANEDIOL DERIVATIVES
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP0983221A1

  公开（公告）日：2000-03-08